Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Mar 14;23(5):742–754. doi: 10.1158/1055-9965.EPI-13-0979

Table 4.

HPV vaccine follow-through among Hispanic adolescent females (n=1,639)a

No. Follow-Through / Total No. in Category (weighted %) Bivariate OR (95% CI) Multivariate OR (95% CI)
Total 1025/1639 (59.1) -- --
Year
 2010 402/665 (52.5) ref. ref.
 2011 623/974 (64.0) 1.61 (1.10-2.37)* 1.37 (0.92-2.05)
Daughter characteristics
Age
 13 yr 185/329 (52.9) ref. --
 14 yr 217/342 (59.2) 1.29 (0.71-2.34) --
 15 yr 209/334 (59.2) 1.29 (0.72-2.33) --
 16 yr 226/344 (65.9) 1.72 (0.95-3.12) --
 17 yr 188/290 (57.0) 1.18 (0.63-2.19) --
Race
 White 868/1389 (58.8) ref. --
 Black 64/94 (62.5) 1.17 (0.55-2.49) --
 Other 93/156 (60.0) 1.05 (0.54-2.06) --
Visited healthcare provider in last year
 No 156/268 (52.3) ref. --
 Yes 860/1355 (61.0) 1.43 (0.86-2.39) --
Currently live in state where born
 No 247/449 (49.3) ref. ref.
 Yes 778/1190 (62.4) 1.70 (1.12-2.60)* 1.53 (0.96-2.45)
Healthcare coverage
 Through parent employer or union 440/655 (64.0) 2.75 (1.45-5.21)* 1.98 (0.98-4.00)
 Other insurance, including Medicaid 493/788 (61.3) 2.45 (1.33-4.49)* 2.40 (1.26-4.57)*
 No insurance 84/180 (39.3) ref. ref.
Eligible for VFC program
 No 472/711 (63.9) ref. --
 Yes 551/926 (55.7) 0.71 (0.48-1.05) --
Parent characteristics
Mother’s age
 <35 yr 119/219 (41.7) ref. ref.
 35-44 yr 529/841 (60.7) 2.15 (1.24-3.75)* 2.29 (1.22-4.28)*
 45+ yr 377/579 (64.8) 2.57 (1.44-4.61)* 2.11 (1.08-4.14)*
Mother’s education
 Less than high school 307/545 (51.7) ref. ref.
 High school 222/355 (60.4) 1.43 (0.86-2.37) 1.49 (0.87-2.53)
 Some college 263/391 (63.5) 1.63 (0.98-2.71) 1.60 (0.91-2.81)
 College graduate 233/348 (71.0) 2.29 (1.35-3.88)* 2.39 (1.19-4.83)*
Mother’s marital status
 Not married 346/565 (58.9) ref. --
 Married 679/1074 (59.2) 1.01 (0.69-1.50) --
Language of NIS-Teen interview
 English 600/951 (60.8) ref. --
 Spanish 424/685 (57.3) 0.87 (0.59-1.27) --
Received provider recommendation to get daughter HPV vaccine
 No 327/568 (53.5) ref. --
 Yes 645/996 (62.6) 1.46 (0.98-2.17) --
Household characteristics
Poverty status
 Below poverty 372/626 (57.0) ref. ref.
 Above poverty, ≤$75,000 387/604 (60.0) 1.13 (0.73-1.76) 0.71 (0.43-1.16)
 Above poverty, >$75,000 226/330 (70.4) 1.80 (1.08-2.99)* 0.78 (0.40-1.55)
Number of children in household
 1 313/472 (70.9) ref. ref.
 2-3 575/910 (61.2) 0.65 (0.42-0.99)* 0.67 (0.43-1.03)
 4+ 137/257 (42.9) 0.31 (0.17-0.55)** 0.42 (0.22-0.81)*
Region of residence
 Northeast 175/256 (64.4) 1.37 (0.86-2.17) --
 Midwest 104/175 (58.1) 1.05 (0.60-1.85) --
 South 425/685 (60.8) 1.17 (0.74-1.84) --
 West 321/523 (57.0) ref. --

Note. HPV = human papillomavirus; OR = odds ratio; CI = confidence interval; ref. = referent group; VFC = Vaccines for Children; NIS-Teen = National Immunization Survey-Teen. Totals may not sum to stated sample size due to missing data. Multivariate model did not include variables with dashes (--). Multivariate model included data on 1544 Hispanic adolescent females due to missing data for potential correlates.

a

Follow-through was defined as receipt of all three doses among only those who initiated the vaccine series (i.e., completion among initiators).

*

p<0.05,

**

p<0.001